Numerous epidemiological, clinical, and animal studies showed that cardiac function and
manifestation of cardiovascular diseases (CVDs) are different between males and females …

Estrogen deficiency is considered to be an important factor leading to cardiovascular
diseases (CVDs). Indeed, the prevalence of CVDs in postmenopausal women exceeds that …

Cancer cells take advantage of signaling cascades to meet their requirements for sustained
growth and survival. Cell signaling is tightly controlled by reversible protein phosphorylation …

Cardiovascular diseases in post-menopausal women are on a rise. Oxidative stress is the
main contributing factor to the etiology and pathogenesis of cardiovascular diseases …

Humans are inevitably exposed to bisphenol A (BPA) via multiple exposure ways. Thus,
attention should be raised to the possible adverse effects related to low doses of BPA …

Introduction Sex hormones may play an important role in age-related cardiac remodeling.
However, their impact on cardiac structure and function in females of advanced age still …

Contradictory findings of estrogen supplementation in cardiac disease highlight the need to
investigate the involvement of estrogen in the progression of heart failure in an animal …

Cardiac hypertrophy is a common phenomenon observed in progressive heart disease
associated with heart failure. Insulin‐like growth factor receptor II (IGF‐IIR) has been much …

Previous studies have demonstrated that calcium‐/calmodulin‐dependent protein kinase II
(CaMKII) and calcineurin A‐nuclear factor of activated T‐cell (CnA‐NFAT) signaling …

Ca2+/calmodulin‐dependent protein kinase II (CaMKII), regulated by inhibitor 1 of protein
phosphatase 1 (I1PP1), is vital for maintaining cardiovascular homeostasis. However, the …